Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.
In: BMC Cancer, Jg. 22 (2022-07-27), Heft 1, S. 1-14
Online
academicJournal
Zugriff:
Titel: |
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.
|
---|---|
Autor/in / Beteiligte Person: | Sommerhäuser, G. ; Kurreck, A. ; Stintzing, S. ; Heinemann, V. ; von Weikersthal, L. Fischer ; Dechow, T. ; Kaiser, F. ; Karthaus, M. ; Schwaner, I. ; Fuchs, M. ; König, A. ; Roderburg, C. ; Hoyer, I. ; Quante, M. ; Kiani, A. ; Fruehauf, S. ; Müller, L. ; Reinacher-Schick, A. ; Ettrich, T. J. ; Stahler, A. |
Link: | |
Zeitschrift: | BMC Cancer, Jg. 22 (2022-07-27), Heft 1, S. 1-14 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1471-2407 (print) |
DOI: | 10.1186/s12885-022-09892-8 |
Sonstiges: |
|